|
NOC3L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.349200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.085000E-01 |
| Normal-vs-Stage2 |
2.567800E-01 |
| Normal-vs-Stage3 |
5.535600E-01 |
| Normal-vs-Stage4 |
8.965800E-01 |
| Stage1-vs-Stage2 |
4.275600E-02 |
| Stage1-vs-Stage3 |
7.251500E-02 |
| Stage1-vs-Stage4 |
4.960600E-01 |
| Stage2-vs-Stage3 |
5.213000E-01 |
| Stage2-vs-Stage4 |
2.479600E-01 |
| Stage3-vs-Stage4 |
5.192000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.498400E-01 |
| Normal-vs-AfricanAmerican |
7.469800E-02 |
| Normal-vs-Asian |
2.537200E-01 |
| Caucasian-vs-AfricanAmerican |
6.040200E-02 |
| Caucasian-vs-Asian |
1.669790E-01 |
| AfricanAmerican-vs-Asian |
4.944600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.886400E-01 |
| Normal-vs-Female |
3.625600E-01 |
| Male-vs-Female |
1.253960E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.417400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.619000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.337000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.908800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.232200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.011600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.743600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.309600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.285800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.794600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.941200E-01 |
| Classical-VS-Follicular |
7.755600E-03 |
| Classical-VS-Other |
2.946000E-01 |
| Classical-VS-Normal |
2.617200E-01 |
| Tall-VS-Follicular |
5.408400E-01 |
| Tall-VS-Other |
6.015200E-01 |
| Tall-VS-Normal |
8.791600E-01 |
| Follicular-VS-Other |
9.137600E-01 |
| Follicular-VS-Normal |
3.211200E-01 |
| Other-VS-Normal |
5.092600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.545000E-01 |
| Normal-vs-N1 |
4.550000E-01 |
| N0-vs-N1 |
1.852360E-01 |
|
|
